![](https://s2.storage.snapzu.com/c7/a7/70/a5/kxh/snaps/79/dc/220162/thumbs/b1bbe7b13a577063_fpi_large.jpg)
![](https://s2.storage.snapzu.com/c7/a7/70/a5/kxh/profile/6c5759bb9142366e.jpg)
6 years ago
1
Pharmaceutical companies are backing away from a growing threat that could kill 10 million people a year by 2050
Just two years after Novartis announced it would embrace the challenge of searching for cures for life-threatening infections known as superbugs, the drugmaker said last week it would exit antibacterial and antiviral research.
Continue Reading![](https://s0.storage.snapzu.com/favicons/b/u/s/i/www.businessinsider.com.au.png)
Additional Contributions:
Join the Discussion
Well,I suspected this would be happening. We brought this mess on ourselves and it sure does not look good for us.